Complementary and alternative treatments for insomnia/insomnia -depression-anxiety symptom cluster: Meta-analysis of English and Chinese literature

Ji, Xiaowen; Ivers, Hans; Beaulieu‐Bonneau, Simon; Morin, Charles M.

doi:10.1016/j.smrv.2021.101445

Cited by 18 publications

(15 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, the original version of the ISI and the PSQI are the most commonly used, and the original version of the ISI remains the only validated scale that is highly recommended for all insomnia research protocols. Dr. Morin has also conducted extensive research on cognitive behavioral therapy for insomnia and its comorbidities ( 110 , 111 ). His team’s current efforts continue to focus on evaluating the efficacy of cognitive behavioral therapy and optimizing the procedural approach ( 112 , 113 ).…”

Section: Discussionmentioning

confidence: 99%

The top 100 most cited papers in insomnia: A bibliometric analysis

Wan

Wang

et al. 2023

Front. Psychiatry

View full text Add to dashboard Cite

ObjectiveThe number of citations to a paper represents the weight of that work in a particular area of interest. Several highly cited papers are listed in the bibliometric analysis. This study aimed to identify and analyze the 100 most cited papers in insomnia research that might appeal to researchers and clinicians.MethodsWe reviewed the Web of Science (WOS) Core Collection database to identify articles from 1985 to 24 March 2022. The R bibliometric package was used to further analyze citation counts, authors, year of publication, source journal, geographical origin, subject, article type, and level of evidence. Word co-occurrence in 100 articles was visualized using VOS viewer software.ResultsA total of 44,654 manuscripts were searched on the Web of Science. Between 2001 and 2021, the top 100 influential manuscripts were published, with a total citation frequency of 38,463. The top countries and institutions contributing to the field were the U.S. and Duke University. Morin C.M. was the most productive author, ranking first in citations. Sleep had the highest number of manuscripts published in the top 100 (n = 31), followed by Sleep Medicine Reviews (n = 9). The most cited manuscript (Bastien et al., Sleep Medicine, 2001; 3,384 citations) reported clinical validation of the Insomnia Severity Index (ISI) as a brief screening indicator for insomnia and as an outcome indicator for treatment studies. Co-occurrence analyses suggest that psychiatric disorders combined with insomnia and cognitive behavioral therapy remain future research trends.ConclusionThis study provides a detailed list of the most cited articles on insomnia. The analysis provides researchers and clinicians with a detailed overview of the most cited papers on insomnia over the past two decades. Notably, COVID-19, anxiety, depression, CBT, and sleep microstructure are potential areas of focus for future research.

show abstract

Section: Discussionmentioning

confidence: 99%

The top 100 most cited papers in insomnia: A bibliometric analysis

Wan

Wang

et al. 2023

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

“…Fifthly, the mediumto long-term efficacy of acupuncture on DI remains elusive as only five studies (26,27,37,42,46) included follow-up. Sixthly, we excluded DI in or following stroke, cancer survivors, chronic pain, and feminine-specific physiological stage from the literature screening phase, although these conditions are quite common and the symptom cluster of sleep and emotional dysregulation in these special populations could be more severe (19). Caution thereby should be exercised in generalizing the positive benefits of the current review to DI in these special populations as mentioned.…”

Section: Strengths Limitations and Comparison With Previous Systemati...mentioning

confidence: 99%

“…These two RCTs are well-designed and graded as high-quality studies as assessed with the modified Jadad system and the Cochrane tool. We cannot deny the placebo effect of acupuncture; indeed, in the management of insomnia, positive beliefs, anticipation, and expectations concerning CAM may result in more favorable outcomes and higher satisfaction with CAM, i.e., the placebo effect (19,77). The only concern of those two trials (26,37) is if the acupuncture treatment was sufficient.…”

Section: Interpretation Of Findingsmentioning

confidence: 99%

“…Complementary and alternative medicine (CAM) is becoming popular in the management of the insomnia-depression-anxiety symptom cluster (19); some evidence-based clinical practice guidelines (CPGs) in the Euro-American and Asian-Pacific regions include CAM therapies to inform clinicians' practice decisions on various types of insomnia (20). Acupuncture, an integral component of CAM, is a non-pharmaceutical therapy of traditional Chinese medicine (TCM) that stems from ancient clinical practice and has been widely practiced in China for over 4,000 years (21,22).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Role of Acupuncture in the Management of Insomnia as a Major or Residual Symptom Among Patients With Active or Previous Depression: A Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

BackgroundDue to concerns about risks associated with antidepressants and/or hypnotics, complementary therapies such as acupuncture have been sought by patients with active or previous depression to manage insomnia. This systematic review aimed to clarify if acupuncture is effective and safe enough to be recommended as an alternative or adjuvant therapy to standard care in ameliorating concomitant or residual insomnia, two types of insomnia associated with depression.MethodsRandomized controlled trials (RCTs) of depression-related insomnia (DI) treatment via acupuncture vs. waitlist-control or placebo-/sham-acupuncture and RCTs of DI treatment via acupuncture alone or combined with standard care [Western pharmacotherapy and/or cognitive-behavioral therapy (CBT)] vs. standard care alone were searched for from seven databases from inception to December 2021. Cochrane criteria were followed.ResultsTwenty-one studies involving 1,571 participants were analyzed. For insomnia as a major symptom of active depression, meta-analyses suggested that acupuncture significantly reduced the global scores of both the Pittsburg Sleep Quality Index (PSQI) [MD = −3.12, 95% CI (−5.16, −1.08), p < 0.01] and Hamilton Depression Scale (HAMD) [SMD = −2.67, 95% CI (−3.51, −1.84), p < 0.01], in comparison with placebo-acupuncture. When compared with conventional pharmacotherapy (antidepressants and/or hypnotics), the results favored acupuncture in decreasing PSQI [MD = −1.17, 95% CI (−2.26, −0.08), p = 0.03] and HAMD [SMD = −0.47, 95% CI (−0.91, −0.02), p = 0.04]. Acupuncture was comparable to conventional pharmacotherapy in reducing scores of each domain of PSQI. For insomnia as a residual symptom of previous or partially remitted depression, acupuncture conferred a very limited, non-significant therapeutic advantage against sham-/placebo-acupuncture. Whether acupuncture has an add-on effect to conventional pharmacotherapy in this type of insomnia has not been investigated. Also, no study was available to address the efficacy differences between acupuncture and CBT or the synergistic effect of these two therapies.ConclusionsThere is a low to moderate level of evidence supporting acupuncture as a safe and effective remedy alternative to or adjuvant to conventional pharmacotherapy (antidepressant and/or hypnotic) in improving insomnia and other depression symptoms among patients with active depression. Furthermore, the patients' complaint of disrupted sleep continuity is most likely to benefit from acupuncture. The benefit of acupuncture on residual insomnia associated with previous or partially remitted depression is limited. Future acupuncture studies need to consider applying optimal dosage and addressing deficiencies in trial quality.Systematic Review Registration:https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021269880, PROSPERO, identifier: CRD42021269880.

show abstract

“…Insomnia co-exists with other common psychiatric disorders such as major depressive disorder, generalized anxiety disorder [ 20 ], and posttraumatic stress disorder [ 21 ]. In Hong Kong, the prevalence of insomnia in the general population was estimated at 11.9% [ 22 ] based on the presence of difficulty initiating sleep, difficulty maintaining sleep, or early-morning awakening occurring at least three nights per week in the past month.…”

Section: Introductionmentioning

confidence: 99%

Evaluating the Efficacy of Electrical Vestibular Stimulation (VeNS) on Insomnia Adults: Study Protocol of a Double-Blinded, Randomized, Sham-Controlled Trial

Cheung

Lam

Fong

et al. 2023

IJERPH

View full text Add to dashboard Cite

Insomnia is a common health problem in the general population. There are different ways to improve sleeping habits and quality of sleep; however, there is no clinical trial using transdermal neurostimulation to treat individuals with symptoms of insomnia in Asia. This gives us the impetus to execute the first study in Asia which aims to evaluate the efficacy of Electrical Vestibular Stimulation (VeNS) on individuals with insomnia in Hong Kong. This study proposes a two-armed, double-blinded, randomized, sham-controlled trial including the active VeNS and sham VeNS group. Both groups will be measured at baseline (T1), immediately after the intervention (T2), and at the 1-month (T3) and 3-month follow-up (T4). A total of 60 community-dwelling adults aged 18 to 60 years, with insomnia symptoms will be recruited in this study. All subjects will be computer randomized into either the active VeNS group or the sham VeNS group on a 1:1 ratio. All subjects in each group will receive twenty 30-min VeNS sessions during weekdays, which will be completed in a 4-week period. Baseline measurements and post-VeNS evaluation of the psychological outcomes (i.e., insomnia severity, sleep quality and quality of life) will also be conducted on all participants. The 1-month and 3-month follow-up period will be used to assess the short-and long-term sustainability of the VeNS intervention. For statistical analysis, a mixed model will be used to analyze the repeated measures data. Missing data will be managed by multiple imputations. The level of significance will be set to p < 0.05. Significance of the study: The results of this study will be used to determine whether this VeNS device can be considered as a self-help technological device to reduce the severity of insomnia in the community setting. We registered this clinical trial with the Clinical trial government, identifier: NCT04452981.

show abstract

Complementary and alternative treatments for insomnia/insomnia -depression-anxiety symptom cluster: Meta-analysis of English and Chinese literature

Cited by 18 publications

References 76 publications

The top 100 most cited papers in insomnia: A bibliometric analysis

The top 100 most cited papers in insomnia: A bibliometric analysis

The Role of Acupuncture in the Management of Insomnia as a Major or Residual Symptom Among Patients With Active or Previous Depression: A Systematic Review and Meta-Analysis

Evaluating the Efficacy of Electrical Vestibular Stimulation (VeNS) on Insomnia Adults: Study Protocol of a Double-Blinded, Randomized, Sham-Controlled Trial

Contact Info

Product

Resources

About